Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.



Research groups

Pavandeep Rai

Postdoctoral Research Scientist

I studied undergraduate Biochemistry at the University of Birmingham during which, I completed a year in Industry at Astra Zeneca studying drug induced mitochondrial toxicity. Following this I joined the Wellcome Trust Centre for Mitochondrial Research, Newcastle University and conducted an MRes, characterising mitochondrial physiology in patient derived induced pluripotent stem cells (iPSCs) and a PhD developing assays to identify compounds for the treatment of mitochondrial disease in collaboration with Novartis. Following this, I conducted pre-clinical assessment of compounds for Reneo Pharmaceuticals to determine the effect of lead therapies on mitochondrial function in Complex I deficient iPSC derived myotubes.

I joined the Wade-Martins group in 2018 and will be conducting novel target identification and validation for the treatment of Parkinson’s disease alongside the pharmaceutical company FORMA therapeutics.